4104 — Excelsior Medical Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeSmall Cap

Annual income statement for Excelsior Medical Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	6,457	6,675	6,573	7,187	8,233
Cost of Revenue
Gross Profit	1,238	1,307	1,374	1,514	1,670
Selling / General / Administrative Expenses
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	6,010	6,146	5,978	6,580	7,531
Operating Profit	447	529	595	607	703
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	747	829	874	964	1,144
Provision for Income Taxes
Net Income After Taxes	622	669	722	785	923
Minority Interest
Net Income Before Extraordinary Items
Net Income	515	572	607	667	747
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	515	572	607	667	747
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	3.36	3.69	3.87	4.26	4.67
Dividends per Share